Form 8.3 SPIRE HEALTHCARE GROUP PLC

Summary by AI BETAClose X

Barclays disclosed on 16 Nov 2026 (positions held 13 Nov 2026) an aggregate economic exposure to Spire Healthcare of 13,323,196 long shares (3.31%) and 13,352,722 short positions (3.32%), leaving a net short of 29,526 shares (~0.01 percentage point). The position comprises 7,116,716 directly owned/controlled shares (1.77%) and cash-settled derivatives of 6,206,480 long (1.54%) and 7,151,354 short (1.78%); no stock-settled derivatives or subscription rights were reported. Barclays executed net purchases of 172,282 ordinary shares across trades at approximately £2.475–£2.4825 per share.

Disclaimer*

UK 100

Latest directors dealings